3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Prostatic Neoplasms
47
Glioblastoma
47
Breast Neoplasms
40
Esophageal Neoplasms
36
Rectal Neoplasms
35
Carcinoma, Non-Small-Cell Lung
34
Lung Neoplasms
33
Head and Neck Neoplasms
29
Squamous Cell Carcinoma of Head and Neck
26
Brain Neoplasms
23
Pancreatic Neoplasms
22
Neoplasms
19
Uterine Cervical Neoplasms
17
Oropharyngeal Neoplasms
16
Neoplasm Metastasis
16
Gliosarcoma
16
Esophageal Squamous Cell Carcinoma
16
Glioma
15
Sarcoma
14
Melanoma
14
Stomach Neoplasms
12
Adenocarcinoma Of Esophagus
12
Lymphoma, Follicular
9
Carcinoma, Squamous Cell
9
Mouth Neoplasms
8
Lymphoma, B-Cell, Marginal Zone
8
Anus Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Leukemia, Myeloid, Acute
7
Endometrial Neoplasms
7
Interventions
Cisplatin
6
Cetuximab
4
Drug Therapy
3
Resistance Training
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Nutritional Status
2
Hydroxyurea
2
Fluorouracil
2
Erlotinib Hydrochloride
2
Bevacizumab
2
zimberelimab
1
temsirolimus
1
Valproic Acid
1
Sirolimus
1
Radiation
1
Psychology, Positive
1
Methods
1
Metabolic Flux Analysis
1
Immunoglobulin G
1
Etoposide
1
Docetaxel
1
Disulfides
1
Cyclophosphamide
1
Cryosurgery
1
Chemoradiotherapy
1
Celecoxib
1
Carboplatin
1
CP protocol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Pharyngeal Neoplasms
×
Radiation
×
Clear all
NCT04892875
2023-11-30
PANTHEoN
Vanderbilt-Ingram Cancer Center
Phase 1
Withdrawn